Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. RCDTF.PINK

Recordati Industria Chimica e Farmaceutica S.p.A (RCDTF PINK) stock market data APIs

$51.6 0(0%) as of July 25, 2024
Price chart is built with Anychart

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Recordati Industria Chimica e Farmaceutica S.p.A Financial Data Overview

51.6
51.6
-
51.6
51.6
45.4384-51.6
11 564 M
206 M
2 139 M
0.0265
0.392
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RCDTF',
Type: 'Common Stock',
Name: 'Recordati Industria Chimica e Farmaceutica S.p.A',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BW0RW1',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
HomeCategory: NULL,
IsDelisted: false,
}

Recordati Industria Chimica e Farmaceutica S.p.A Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 139 M
  • EBITDA 774 M
  • Earnings Per Share 1.98
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Recordati Industria Chimica e Farmaceutica S.p.A Earnings via APIs

  • Latest Release 2024-07-30
  • EPS/Forecast NaN

Get Recordati Industria Chimica e Farmaceutica S.p.A End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Recordati Industria Chimica e Farmaceutica S.p.A latest news via APIs

Italy’s Angelini Eyes Major Pharma Merger to Boost Drug Pipeline

(Bloomberg) -- Italian drugmaker Angelini Pharma SpA is looking at three US biotechs for a potential merger that would expand its global footprint and help it execute an ambitious growth plan. Most R...

KKR, TPG Express Interest in Italian Drugmaker Recordati

(Bloomberg) -- KKR & Co. and TPG Inc. are among suitors to have expressed initial interest in Italian drugmaker Recordati SpA, people familiar with the matter said. Most Read from Bloomberg Flesh-Ea...
Do you have any questions?
support@eodhistoricaldata.com